Sun, May 8, 2011
Sat, May 7, 2011
Fri, May 6, 2011
Thu, May 5, 2011
Wed, May 4, 2011
Tue, May 3, 2011
Mon, May 2, 2011
Fri, April 29, 2011
Thu, April 28, 2011
Wed, April 27, 2011
Tue, April 26, 2011
Mon, April 25, 2011
Fri, April 22, 2011
Thu, April 21, 2011
Wed, April 20, 2011
Tue, April 19, 2011
Mon, April 18, 2011
[ Mon, Apr 18th 2011 ]: Market Wire
00 a.m. ET
Sun, April 17, 2011
Fri, April 15, 2011
Thu, April 14, 2011
Wed, April 13, 2011
Tue, April 12, 2011

NeuroMetrix, Inc. Announces Date for 2011 First Quarter Financial Results Conference Call


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. t-quarter-financial-results-conference-call.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

WALTHAM, Mass.--([ BUSINESS WIRE ])--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2011 first quarter financial results before the opening of the market on April 28, 2011. The Company will host a conference call at 8:00 am eastern time on April 28, 2011 to discuss its first quarter financial results as well as business developments affecting the Company.

The conference call may be accessed in the United States by dialing 800-920-8624 and using the confirmation code 78285474. Internationally, the conference call may be accessed by dialing 617-597-5430 and using the same confirmation code. The earnings press release and accompanying condensed financial statements will be accessible from the Company's website at [ www.neurometrix.com ] under the "Investors" tab.

A replay of the conference call will be available starting two hours after the call by dialing 888-286-8010, domestically and 617-801-6888, internationally. The confirmation code to access the replay is 82726821. The replay will be available for three months after the conference call.

About NeuroMetrix

NeuroMetrix is a science-based health care company transforming patient care through neurotechnology. We develop and market innovative products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease and spinal stenosis. For more information, visit [ http://www.neurometrix.com ].


Publication Contributing Sources